| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159736 | The Journal of Urology | 2009 | 7 Pages |
Abstract
Prostate specific antigen was significantly lower in aspirin users with latent cancer. Prostate volume was not associated with nonsteroidal anti-inflammatory drug use. Results suggest that aspirin may affect prostate cancer detection, suggesting a potential detection bias to address in future studies of nonsteroidal anti-inflammatory drugs and prostate cancer prevention.
Keywords
COXPSANSAIDWHRAspirinProstate specific antigencyclooxygenasecardiovascular diseasenonsteroidal anti-inflammatory drugCVDbody mass indexBMIAnti-inflammatory agentsNon-steroidalProstatic neoplasmsHigh grade prostatic intraepithelial neoplasiawaist-to-hip ratioBenign prostatic hyperplasiaBPHprostate-specific antigenProstateprostaglandinPIN
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jay H. Fowke, Saundra S. Motley, Joseph A. Jr., Michael S. Cookson, Raoul Concepcion, Sam S. Chang, Susan Byerly,